“Maintenance of Response With Certolizumab Pegol for the Treaatment of Chronic Plaque Psoriasis: Results of a 32-Week Re-Randomized Maintenance Period from an Onging Phase 3, Multicenter, Randomized, Active- and Placebo-Controlled Study (CIMPACT)”. SKIN The Journal of Cutaneous Medicine 1, no. 3.1 (October 27, 2017): s24. Accessed April 18, 2025. https://skin.dermsquared.com/skin/article/view/119.